Angle-closure glaucoma after discontinuing donepezil hydrochloride (ARICEPT)

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 8, 2005, Pages 1083-

  Enzenauer, Robert W ^a,b   Bowers, Patrick J ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b Department of Ophthalmology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CONJUGATED ESTROGEN; DONEPEZIL; NEUROLEPTIC AGENT;

ADULT; ALZHEIMER DISEASE; CASE REPORT; CLOSED ANGLE GLAUCOMA; CORNEA EDEMA; DRUG WITHDRAWAL; ESTROGEN THERAPY; FEMALE; HEADACHE; HUMAN; LETTER; NAUSEA AND VOMITING; PHOTOPHOBIA; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

EID: 24144479985     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.8.1083     Document Type: Letter

References (2)

1. Approved package insert. Donepezil hydrochloride (Aricept). Teaneck, NJ: Eisai, Inc., and New York, NY: Pfizer, Inc.; 1997.
2. Mandelkorn RM. Nonsteroidal drugs and glaucoma. In: Ritch R, Shields MB, Krupin T. The Glaucomas, 2nd Ed. St. Louis, MO: Mosby; 1996:1189-1204.